Guardian Pharmacy Services (NYSE:GRDN) Reaches New 52-Week High - Time to Buy?

Key Points

• Guardian Pharmacy Services hit a 52-week high, reaching $48.77 and last trading at $48.31, up from its prior close of $47.02.
• Analyst sentiment is broadly positive: nine analysts rate the stock Buy and one Hold, for a “Moderate Buy” consensus. The average price target of $45.57 is below the latest share price.
• The company beat quarterly estimates, reporting EPS of $0.33 versus $0.31 expected and revenue of $371.07 million versus $365.76 million expected.

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) reached a new 52-week high during trading on Tuesday. The stock traded as high as $48.77 and last traded at $48.31, with a volume of 275,237 shares changing hands. The stock had previously closed at $47.02.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Weiss Ratings cut shares of Guardian Pharmacy Services from a "buy (b)" rating to a "buy (b-)" rating in a research report on Friday, October 23rd. Wall Street Zen cut shares of Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a research report on Sunday, October 25th. Truist Financial boosted their price target on Guardian Pharmacy Services from $47.00 to $51.00 and gave the stock a "buy" rating in a report on Monday, September 21st. KeyCorp began coverage on shares of Guardian Pharmacy Services in a research report on Tuesday, September 22nd. They issued an "overweight" rating and a $52.00 target price on the stock. Finally, Oppenheimer boosted their price target on Guardian Pharmacy Services from $43.00 to $49.00 and gave the stock an "outperform" rating in a report on Friday, August 7th. Nine research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $45.57.

Guardian Pharmacy Services Stock Performance

The stock has a market cap of $2.42 billion, a PE ratio of 41.21, a P/E/G ratio of 2.20 and a beta of 0.06. The business has a 50 day moving average price of $41.61 and a two-hundred day moving average price of $38.39.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Thursday, November 5th. The company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.02. The company had revenue of $371.07 million during the quarter, compared to the consensus estimate of $365.76 million. Guardian Pharmacy Services had a return on equity of 29.97% and a net margin of 4.50%. As a group, research analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Voya Investment Management LLC purchased a new position in Guardian Pharmacy Services in the third quarter worth about $238,000. Teachers Retirement System of The State of Kentucky boosted its holdings in shares of Guardian Pharmacy Services by 54.7% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 38,372 shares of the company's stock worth $1,565,000 after buying an additional 13,572 shares during the last quarter. Bessemer Group Inc. grew its position in Guardian Pharmacy Services by 3.2% during the third quarter. Bessemer Group Inc. now owns 565,598 shares of the company's stock valued at $23,064,000 after buying an additional 17,569 shares during the period. Riverbridge Partners LLC grew its position in Guardian Pharmacy Services by 4.1% during the third quarter. Riverbridge Partners LLC now owns 254,630 shares of the company's stock valued at $10,384,000 after buying an additional 10,045 shares during the period. Finally, Alps Advisors Inc. purchased a new stake in Guardian Pharmacy Services during the third quarter valued at approximately $509,000.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc. provides pharmacy services to people living in long-term care and residential care settings. Its customers include assisted living and skilled nursing communities, behavioral health facilities, and other group-living providers. The company supplies prescription medications and offers medication packaging, delivery, consulting, and clinical support. Its services are designed to help care providers manage residents' medication needs and support continuity of care. Founded in 2004, Guardian operates a network of pharmacies serving communities across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.